Article
Gait Abnormalities and Aberrant D2 Receptor Expression and Signaling in Mice Carrying the Human Pathogenic Mutation DRD2I212F.
Molecular pharmacology - 1 Mar 2023
Rodriguez-Contreras Dayana, Gong Sheng, Lebowitz Joseph J, Fedorov Lev M, Asad Naeem, Dore Timothy M, Phillips Tamara J, Ford Christopher P, Williams John T, Neve Kim A
Abstract excerpt
A dopamine D2 receptor mutation was recently identified in a family with a novel hyperkinetic movement disorder. That allelic variant D2-I212F is a constitutively active and G protein-biased receptor. We now describe mice engineered using CRISPR-Cas9-mediated gene editing technology to carry the D2-I212F variant. Drd2I212F mice exhibited gait abnormalities resembling those in other mouse models of chorea and/or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
